Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
MayFirst in the world to develop heart progenitor cells from embryonic stems cells, giving new hope for testing drugs and treating heart failure patients. (Dr. Gordon Keller)
JanuaryGenerated polyhormonal cells that were insulin prodicing. (Dr. Gordon Keller)
AugustIdentify new approaches to mature liver cells to stage of efficient drug metabolization. (Dr. Gordon Keller)
NovemberIsolate pure population of cardiomyocytes and identifies epicardium and endocardium. (Dr. Gordon Keller)
FebruaryDr. John Dick discovers a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in patients with acute myeloid leukemia (AML).
MayDevelops human cartilage tissue from human stem cells. (Dr. Gordon Keller)
AugustDemonstrates a new method to produce cholangiocytes (bile duct cells) from human pluripotent stem cells, based on providing the stem cells with certain activators at specific times during the production process. (Dr. Gordon Keller)
December 12McEwen Centre receives backing from BlueRock Therapeutics.
Work of UHN scientists among first projects for new stem-cell research company to commercialize an approach to regenerating heart muscle in patients who have had a heart attack or suffer from chronic heart failure.
December 14Develop the first functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy. (Dr. Gordon Keller and Dr. Stephanie Protze)
August 24Develop a new method to identify and purify cells that develop into insulin-producing cells from human stem cells, creating opportunities for new therapies and safer transplants in patients with type 1 diabetes. (Dr. Maria Cristina Nostro)
December 6McEwen Stem Cell Institute is established.